Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
National Health Investors ( (NHI) ) has shared an update.
On September 26, 2025, National Health Investors, Inc. completed a public offering of $350 million in 5.350% Senior Notes due 2033, guaranteed by subsidiary guarantors. The offering, governed by a base indenture and a supplemental indenture, includes restrictive covenants and was made under a registration statement filed with the SEC. The Notes, which are senior unsecured obligations, were offered at 98.903% of the principal amount and bear interest payable semi-annually. The company may redeem the Notes at specified prices before maturity, and the indenture outlines events of default.
The most recent analyst rating on (NHI) stock is a Hold with a $80.00 price target. To see the full list of analyst forecasts on National Health Investors stock, see the NHI Stock Forecast page.
Spark’s Take on NHI Stock
According to Spark, TipRanks’ AI Analyst, NHI is a Outperform.
National Health Investors is performing well with strong financials, positive technical indicators, and a promising earnings call. The company’s strategic focus on growth and a recent dividend increase further enhance its attractiveness. However, a relatively high P/E ratio suggests caution regarding valuation.
To see Spark’s full report on NHI stock, click here.
More about National Health Investors
Average Trading Volume: 233,849
Technical Sentiment Signal: Buy
Current Market Cap: $3.77B
See more insights into NHI stock on TipRanks’ Stock Analysis page.